Dauch Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Dauch Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,948	6,266	7,270	6,531	4,711	5,157	5,802	6,080	6,125	5,837
Cost of revenue	3,222	5,147	6,130	5,628	4,128	4,434	5,098	5,455	5,384	5,132
Gross profit	726	1,119	1,140	903	583	723	705	624	741	705
Research and development	140	162	146	145	117	117	144	155	159	147
Selling, general and administrative	314	390	386	365	314	344	345	367	387	389
Operating income	381	543	106	-302	-396	241	244	147	241	112
Interest expense	93.4	196	216	217	212	195	175	202	186	201
Interest income	2.9	2.9	2	5.8	11.6	10.9	17	26.2	28.1	39.8
Other non-operating income	-81.7	-203	-220	-231	-5.2	-3.2	-1.8	8.1	-20	3.8
Pre-tax income	299	340	-114	-533	-610	1.2	66.3	-24.5	62.8	1.5
Income tax	58.3	2.5	-57.1	-48.9	-49.2	-4.7	2	9.1	27.8	21.2
Net income to minority interests	0	0.4	0.7	0.4	0.2	0	0
Net income	241	337	-57.5	-485	-561	5.9	64.3	-33.6	35	-19.7
EBITDA	583	972	635	235	126	785	736	634	711	572
EPS, basic	3.08	3.22	-0.51	-4.31	-4.96	0.05	0.54	-0.29	0.29	-0.17
EPS, diluted	3.06	3.21	-0.51	-4.31	-4.96	0.05	0.53	-0.29	0.29	-0.17
Shares, basic (weighted)	76.4	102	112	112	113	114	115	117	118	118
Shares, diluted (weighted)	76.9	103	112	112	113	114	116	117	118	118

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	481	377	476	532	557	530	512	520	553	709
Receivables	560	1,036	967	815	793	763	820	819	709	733
Inventory	182	392	460	374	323	410	464	483	443	466
Other current assets	75.8	140	127	137	204	153	198	185	152	230
Total current assets	1,299	1,945	2,030	1,858	1,877	1,856	1,993	2,007	1,915	3,635
Property, plant and equipment	1,094	2,403	2,514	2,358	2,164	1,996	1,903	1,761	1,623	1,592
Lease right-of-use assets				119	117	124	107	116	110	122
Goodwill	154	1,654	1,142	699	186	184	182	182	172	174
Intangible assets	28.5	1,213	1,111	865	781	697	616	533	457	375
Other non-current assets	243	379	449	459	448	457	421	477	472	408
Total assets	3,422	7,883	7,511	6,645	5,916	5,636	5,469	5,356	5,060	6,670
Accounts payable	382	799	840	624	579	613	734	774	701	718
Accrued liabilities	139	200	179	154	171	195	187	200	193	255
Deferred revenue	24.6	34.1	44.3	18.9	23.4	28.1	28.1	16.6	14.2	38.5
Short-term debt	3.3	5.9	122	28.7	13.7	18.8	75.9	17	47.9	10.4
Total current liabilities	652	1,216	1,357	1,026	979	1,040	1,199	1,202	1,175	1,234
Long-term debt	1,413	4,045	3,754	3,664	3,487	3,119	2,897	2,795	2,612	4,083
Lease liabilities				96.7	94.4	99.9	87.2	95.5	89.9	100
Other non-current liabilities	866	1,157	981	1,026
Total liabilities	2,918	6,343	6,024	5,664	5,543	5,178	4,842	4,751	4,497	6,030
Total debt	3.3	5.9	122	28.7	3,441	3,086	2,845	2,752	2,577	4,039
Paid-in capital	660	1,265	1,293	1,314	1,333	1,352	1,369	1,383	1,398	1,411
Retained earnings	424	761	704	249	-320	-314	-250	-283	-248	-268
Treasury stock	-191	-198	-202	-209	-212	-216	-218	-233	-236	-239
Other comprehensive income					-432	-365	-275	-263	-352
Shareholders' equity	504	1,536	1,484	978	371	458	627	605	563	640
Minority interests	0	4	2.4	2.8	2.7	0				0
Total equity	504	1,540	1,486	980	373	458	627	605	563	640
Total liabilities and equity	3,422	7,883	7,511	6,645	5,916	5,636	5,469	5,356	5,060	6,670
Shares outstanding	76.5	111	112	113	113	114	115	117	118	119

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	241	338	-56.8	-484	-561	5.9	64.3	-33.6	35	-19.7
Depreciation and amortization	202	429	529	537	522	544	492	487	470	460
Stock-based compensation	21	43.4	27.9	22.4	19.4	18.2	17.7	13.4	15	13.6
Deferred income tax	30.4	-146	-25.3	-86.4	-71.9	-42.5	-32.8	-38.3	-40.1	-31.9
Change in receivables	-19.3	-44.9	56.1	63.9	28.9	23.1	-38.7	7.2	70.3	-22.7
Change in inventory	12.2	2.5	-83.1	56.1	53.7	-87.7	-16.2	-13.2	17.1	-7
Change in payables	-14.2	-12.6	7.5	-97.7	-37.1	62.7	61.1	58.6	-64.2	93.3
Cash from operations	408	647	772	560	455	538	449	396	455	412
Capital expenditures	-223	-478	-525	-433	-216	-181	-171	-195	-248	-257
Acquisitions	-5.6	-896	-1.3	-9.4	0	-4.9	-88.9	-2.5	-7.3	-2.5
Cash from investing	-228	-1,378	-478	-307	-218	-161	-243	-185	-255	-170
Debt issued	30.3	2,863	510	356	408	635	248	35.8	7	2,109
Debt repaid	-7	-2,154	-681	-544	-607	-1,018	-458	-185	-155	-677
Stock issued	0.3	0.9	0	0
Share buybacks	-5.2	-7	-3.7	-7.5	-2.7	-4.3	-1.9	-14.7	-2.8	-2.8
Cash from financing	18.4	616	-185	-200	-215	-401	-217	-206	-156	1,396
Exchange rate effect	0.4	11.1	-6.7	0.1	3.2	-2.7	-7.4	2.3	-11.4	15.1
Net change in cash	199	-104	102	53.1	25	-26.8	-18.7	8.4	33	1,653
Free cash flow	185	169	247	126	239	357	278	202	207	155
Interest paid	87.2	183	200	205	192	185	173	186	185	176
Income taxes paid	48.6	31.9	46	57.1	2.1	26.6	40.4	54.9	49.5	54.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.46 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	10.9%	Gross profit / revenue.
Operating margin	1.0%	Operating income / revenue.
EBITDA margin	8.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-2.3%	Pre-tax income / revenue.
Net margin	-2.0%	Net income / revenue.
FCF margin	-0.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.7%	Cash from operations / revenue.
Return on equity (ROE)	-11.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.5%	Net income / average total assets.
Return on invested capital (ROIC)	1.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	6.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.0%	Capital expenditures / revenue.
D&A / revenue	7.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-4.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-53.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-22.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-19.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-8.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	35.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-156.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-158.6%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-9.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-2.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-2.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-25.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-17.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-8.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	13.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	11.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	31.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.40x	Current assets / current liabilities.
Quick ratio	0.90x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.33x	(Cash + short-term investments) / current liabilities.
Debt / equity	3.33x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	45.5%	Total debt / total assets.
Liabilities / assets	86.3%	Total liabilities / total assets.
Net debt	$4.15B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.83x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.27x	Operating income / interest expense.
Working capital	$1.06B	Current assets - current liabilities.
Goodwill and intangibles / assets	9.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$476.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.74x	Revenue / average total assets.
Fixed asset turnover	2.00x	Revenue / average property, plant and equipment.
Inventory turnover	7.33x	Cost of revenue / average inventory.
Days inventory	50 days	365 x average inventory / cost of revenue.
Receivables turnover	5.42x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	85 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	33 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	108.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.70	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$34.63	Revenue / diluted weighted shares.
FCF per share	-$0.10	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.29	Cash from operations / diluted weighted shares.
Book value per share	$6.36	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.01	Tangible book value / shares outstanding.
Cash per share	$3.71	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.30B	Share price x shares outstanding.
Enterprise value	$5.44B	Market cap + total debt - cash - short-term investments.
P/S	0.16x	Market cap / revenue.
P/B	0.86x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.72x	Market cap / tangible book value, when positive.
P/OCF	4.23x	Market cap / cash from operations, when positive.
EV/Sales	0.66x	Enterprise value / revenue.
EV/EBIT	67.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.65x	Enterprise value / EBITDA, when both are positive.
FCF yield	-1.9%	Free cash flow / market cap.
Earnings yield	-12.7%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.6%	(Dividends paid + share buybacks) / market cap.

What was Dauch Corp's revenue in fiscal 2025?

Dauch Corp reported revenue of $5.84B for fiscal 2025, 4.7% lower than the year before.

Was Dauch Corp profitable in fiscal 2025?

No. It reported a net loss of $19.7M.

How much free cash flow did Dauch Corp generate in fiscal 2025?

Cash from operations of $411.6M minus capital expenditures of $256.5M left free cash flow of $155.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Dauch Corp